Granada Hills, CALIFORNIA2 Active Studies

Ankylosing Spondylitis Clinical Trials in Granada Hills, CALIFORNIA

Find 2 actively recruiting ankylosing spondylitis clinical trials in Granada Hills, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
287
Enrolling

Recruiting Ankylosing Spondylitis Studies in Granada Hills

About Ankylosing Spondylitis Clinical Trials in Granada Hills

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Granada Hills, CALIFORNIA. These studies are seeking a combined 287 participants. Research is being sponsored by AstraZeneca, Maze Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Granada Hills — FAQ

Are there ankylosing spondylitis clinical trials in Granada Hills?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Granada Hills, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Granada Hills?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Granada Hills research site will contact you about next steps.

Are clinical trials in Granada Hills free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Granada Hills studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Granada Hills are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov